On March 23, 2020, approximately two months after all briefs
were submitted, the Fed. Cir. has denied the outstanding petitions
for panel rehearing and rehearing en banc in Arthrex,
Inv. v. Smith & Nephew, Inc. (CAFC No. 2018-2140) (
decision here). As a reminder, the Arthrex panel
concluded that the PTAB's Administrative Patent Judges (APJs)
were improperly appointed principal officers under the
Constitution's Appointments Clause. To remedy this deficiency,
the panel severed the APJ's Title 5 removal protections,
thereby (according to the panel) rendering APJs inferior officers
and prospectively curing any Appointments Clause infirmity in PTAB
final written decisions post October 31, 2019. The Fed. Cir.'s
rehearing denial leaves a change to the current Arthrex
remedy in the hands of Congress or the Supreme Court.